Search

Author/Creator Daniels, Gregory A

1. An Open–Label, Randomized, Multi–Center Study Comparing the Sequence of High Dose Aldesleukin (Interleukin–2) and Ipilimumab (Yervoy) in Patients with Metastatic Melanoma. (1st January 2021)

Authors:
Hasanov, Merve; Milton, Denái R.; Sharfman, William H.; Taback, Bret; Cranmer, Lee D.; Daniels, Gregory A; Flaherty, Lawrence; Hallmeyer, Sigrun; Milhem, Mohammed; Feun, Lynn; Hauke, Ralph; Doolittle, Gary; Gregory, Nancy; Patel, Sapna
Journal:
Oncoimmunology
Issue:
Volume 10:Number 1(2021)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Cemiplimab in locally advanced cutaneous squamous cell carcinoma: results from an open-label, phase 2, single-arm trial. Issue 2 (February 2020)

Authors:
Migden, Michael R; Khushalani, Nikhil I; Chang, Anne Lynn S; Lewis, Karl D; Schmults, Chrysalyne D; Hernandez-Aya, Leonel; Meier, Friedegund; Schadendorf, Dirk; Guminski, Alexander; Hauschild, Axel; Wong, Deborah J; Daniels, Gregory A; Berking, Carola; Jankovic, Vladimir; Stankevich, Elizabeth; B...
Journal:
Lancet oncology
Issue:
Volume 21:Issue 2(2020)
Page Start:
294
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Durability of responses in patients with metastatic renal cell carcinoma treated with high dose interleukin-2 (HD IL-2). (4th November 2015)

Authors:
Clark, Joseph I; Morse, Michael A; Wong, Michael KK; McDermott, David F; Kaufman, Howard L; Daniels, Gregory A; Perritt, Jessica C; Hua, Hong; Aung, Sandra
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 3(2015)Supplement 2
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. Efficacy and safety of high-dose interleukin-2 treatment in patients with a history of brain metastases from renal cell carcinoma. (4th November 2015)

Authors:
Chandar, Ashwin; Silk, Ann W; Clark, Joseph I; Daniels, Gregory A; McDermott, David F; Morse, Michael; Wong, Michael KK; Stein, Mark; Mehnert, Janice; Danish, Shabbar; Aung, Sandra; Kaufman, Howard L
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 3(2015)Supplement 2
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

9. Overall survival of metastatic melanoma patients treated with HD IL-2 followed by immune checkpoint blockade of the CTLA-4 or the PD-1 pathways: analysis of data on the current use of HD IL-2. (4th November 2015)

Authors:
Wong, Michael KK; Morse, Michael A; McDermott, David F; Clark, Joseph I; Kaufman, Howard L; Daniels, Gregory A; Perritt, Jessica C; Hua, Hong; Aung, Sandra
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 3(2015)Supplement 2
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗